Medico Remedies posted a net profit of Rs 23.78 millions for the September 2026 quarter, marking a 7.40 percent year-on-year decline from the previous year.

Quarterly Performance Metrics

The company released its financial results for the quarter ending September 30, 2026, detailing top-line expansion alongside a compressed bottom-line figure. Market participants tracking earnings will note the contrasting directions of revenue and profit figures.

  • Sales: Rs. 739.72 millions, up 40.54 percent from Rs. 526.35 millions.
  • Net Profit: Rs. 23.78 millions, down -7.40 percent from Rs. 25.68 millions.
  • Operating Profit: Rs. 44.72 millions, compared to Rs. 44.43 millions.
  • Other Income: Rs. 13.06 millions, down -24.29 percent from Rs. 17.25 millions.

Additional Financial Breakdown

Interest expenses for the company saw a significant jump during the quarter, rising 91.06 percent to Rs. 4.49 millions from Rs. 2.35 millions in the corresponding quarter last year. Profit before tax was reported at Rs. 32.70 millions, representing a decrease of 5.87 percent compared to the same period in the prior fiscal year.

  • PBIDT: Rs. 44.72 millions, shifting 0.65 percent from Rs. 44.43 millions.
  • Depreciation: Rs. 7.53 millions, moving up from Rs. 7.34 millions.
  • PBDT: Rs. 40.23 millions, down -4.40 percent from Rs. 42.08 millions.

The financial figures underscore a period of robust revenue growth tempered by rising interest and operational costs for the reporting period.